When combined with the previously reported changes identified using FAIMS‐facilitated N‐terminomics, this study provides the most comprehensive list of legumain‐dependent proteome changes in the gut, highlighting its contribution to both normal gut physiology and inflammatory bowel diseases (Table S6). Here, LGMN is linked to inflammatory bowel disease.